Catalyst Wire Dossier Catalyst Wire Dossier

Ultra-low strut thickness everolimus-eluting biodegradable polymer stent

everolimus-eluting stent with biodegradable polymer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ultra-low strut thickness everolimus-eluting biodegradable polymer stent, covering 2024-12-09 to 2024-12-09. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention [NA]

See pricing